Changes in structuredness of cytoplasmic matrix in single stimulated lymphocytes from healthy donors and patients with non-malignant and malignant diseases.
作者信息
Hashimoto Y, Takaku F, Yamanaka T
出版信息
Br J Cancer. 1979 Jul;40(1):156-60. doi: 10.1038/bjc.1979.152.
Abstract
摘要
相似文献
1
Changes in structuredness of cytoplasmic matrix in single stimulated lymphocytes from healthy donors and patients with non-malignant and malignant diseases.健康供体以及患有非恶性和恶性疾病患者的单个受刺激淋巴细胞中细胞质基质结构的变化。
Br J Cancer. 1979 Jul;40(1):156-60. doi: 10.1038/bjc.1979.152.
2
3
Measurement of cytoplasmic viscosity by fluorescence polarization in phytohemagglutinin-stimulated and unstimulated human peripheral lymphocytes.通过荧光偏振法测量植物血凝素刺激和未刺激的人外周血淋巴细胞中的细胞质粘度。
J Histochem Cytochem. 1988 Jun;36(6):609-13. doi: 10.1177/36.6.3367046.
4
5
Changes in the structuredness of cytoplasmic matrix (SCM) in human lymphocytes induced by PHA and cancer basic protein as measured in single cells.在单细胞中检测到的由PHA和癌基础蛋白诱导的人淋巴细胞胞质基质（SCM）结构变化。
Br J Cancer. 1976 May;33(5):539-43. doi: 10.1038/bjc.1976.85.
6
Detection of melanoma by monitoring the intracellular fluorescein fluorescence polarization changes in lymphocytes.通过监测淋巴细胞内荧光素荧光偏振变化来检测黑色素瘤。
Cancer Detect Prev. 1997;21(2):167-77.
7
8
Evaluation of cellular fluidity of peripheral blood lymphocytes from patients with urogenital cancers by a fluorescence polarization technique: PHA response and prognosis.应用荧光偏振技术评估泌尿生殖系统癌症患者外周血淋巴细胞的细胞流动性：PHA反应与预后
Eur J Cancer Clin Oncol. 1981 Oct;17(10):1105-15. doi: 10.1016/0014-2964(81)90295-4.
9
10
Detection of colon cancer by monitoring the intracellular fluorescein fluorescence polarization changes in lymphocytes.通过监测淋巴细胞内荧光素荧光偏振变化检测结肠癌
Cancer Detect Prev. 1996;20(4):300-7.
引用本文的文献
1
Reactivity of lymphocytes to basic proteins prepared from brain glioma and stomach cancer with MEM test.采用微量培养试验检测淋巴细胞对脑胶质瘤和胃癌制备的碱性蛋白的反应性。
Br J Cancer. 1981 Apr;43(4):532-6. doi: 10.1038/bjc.1981.76.
2
The SCM test for cancer. an evaluation in terms of lymphocytes from healthy donors and cancer patients.用于癌症检测的SCM试验：基于健康供体和癌症患者淋巴细胞的评估
Br J Cancer. 1980 May;41(5):772-7. doi: 10.1038/bjc.1980.140.
本文引用的文献
1
Isolation of an "antigen" from malignant tumours.从恶性肿瘤中分离出一种“抗原”。
Br J Cancer Suppl. 1973 Aug;1:219-23.
2
Rapid preparation of lymphocytes for tissue-typing.用于组织分型的淋巴细胞的快速制备。
Lancet. 1969 Aug 9;2(7615):327. doi: 10.1016/s0140-6736(69)90096-8.
3
Biophysical differentiation between lymphocytes from healthy donors, patients with malignant diseases and other disorders.健康供体、恶性疾病患者及其他疾病患者的淋巴细胞之间的生物物理差异。
Br J Cancer. 1974 May;29(5):345-52. doi: 10.1038/bjc.1974.81.
4
Changes in the structuredness of cytoplasmic matrix (SCM) in human lymphocytes induced by PHA and cancer basic protein as measured in single cells.在单细胞中检测到的由PHA和癌基础蛋白诱导的人淋巴细胞胞质基质（SCM）结构变化。
Br J Cancer. 1976 May;33(5):539-43. doi: 10.1038/bjc.1976.85.
5
Usefulness of the SCM test in the diagnosis of gastric cancer.SCM试验在胃癌诊断中的应用价值。
Br J Cancer. 1977 Dec;36(6):810-3. doi: 10.1038/bjc.1977.266.
6
Application of the phenomenon of changes in the structuredness of cytoplasmic matrix (SCM) in the diagnosis of malignant disorders: a review.细胞质基质结构变化现象在恶性疾病诊断中的应用：综述
Eur J Cancer (1965). 1977 Sep;13(9):903-15. doi: 10.1016/0014-2964(77)90166-9.
Zotero 插件